Biotech · Private company · San Diego, CA, US
Crinetics Pharmaceuticals, Inc.
SEC CIK 0001658247
Track this companyFree. Adds Crinetics Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials165 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- AtumelnantPhase 3 · Congenital Adrenal HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
- PaltusotinePhase 3 · Carcinoid SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- PaltusotinePhase 3 · AcromegalyClinicalTrials.gov · fetched Nov 12, 2026
- atumelnantPhase 2 · Cushing SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- atumelnant (CRN04894)Phase 2 · Congenital Adrenal HyperplasiaClinicalTrials.gov · fetched Nov 12, 2026
- CRN09682Phase 2 · SST2-positive Neuroendocrine NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- Randomized: 40 mg PaltusotinePhase 2 · Carcinoid SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Randomized: 80 mg PaltusotinePhase 2 · Carcinoid SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- AtumelnantPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- CarbamazepinePhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- CRN04894 Oral SolutionPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- DigoxinPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- MetforminPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials16
- Drug-Drug Interaction Study of Atumelnant in Healthy ParticipantsPHASE1 · COMPLETED · started May 28, 2026ClinicalTrials.gov NCT07570082 · fetched Nov 12, 2026
- A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)PHASE2_PHASE3 · RECRUITING · started Jan 22, 2026ClinicalTrials.gov NCT07159841 · fetched Nov 12, 2026
- A Study to Evaluate Atumelnant in Adults With Congenital Adrenal HyperplasiaPHASE3 · RECRUITING · started Dec 11, 2025ClinicalTrials.gov NCT07144163 · fetched Nov 12, 2026
- A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid TumorsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 26, 2025ClinicalTrials.gov NCT07129252 · fetched Nov 12, 2026
- Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine RegimenPHASE3 · ACTIVE_NOT_RECRUITING · started Nov 19, 2025ClinicalTrials.gov NCT07087054 · fetched Nov 12, 2026
- A Study to Assess Pharmacokinetics, Safety, and Tolerability of Atumelnant in Healthy Japanese and Caucasian ParticipantsPHASE1 · COMPLETED · started Oct 28, 2025ClinicalTrials.gov NCT07221084 · fetched Nov 12, 2026
- An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal HyperplasiaPHASE2 · RECRUITING · started Feb 25, 2025ClinicalTrials.gov NCT06712823 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's SyndromePHASE1_PHASE2 · COMPLETED · started Oct 12, 2023ClinicalTrials.gov NCT05804669 · fetched Nov 12, 2026
- Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)PHASE2 · COMPLETED · started Jul 3, 2023ClinicalTrials.gov NCT05907291 · fetched Nov 12, 2026
- Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid SyndromePHASE2 · COMPLETED · started Apr 22, 2022ClinicalTrials.gov NCT05361668 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)PHASE3 · TERMINATED · started Dec 17, 2021ClinicalTrials.gov NCT05192382 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of AcromegalyPHASE3 · TERMINATED · started May 12, 2021ClinicalTrials.gov NCT04837040 · fetched Nov 12, 2026
- Single and Multiple-Ascending Dose Study of CRN04894 in Healthy VolunteersPHASE1 · COMPLETED · started Dec 18, 2020ClinicalTrials.gov NCT06048887 · fetched Nov 12, 2026
- A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)PHASE2 · TERMINATED · started Jan 29, 2020ClinicalTrials.gov NCT04261712 · fetched Nov 12, 2026
- An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge)PHASE2 · COMPLETED · started Mar 12, 2019ClinicalTrials.gov NCT03789656 · fetched Nov 12, 2026
- A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)PHASE2 · COMPLETED · started Mar 11, 2019ClinicalTrials.gov NCT03792555 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Sep 1, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 19, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 14, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 3, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORT FILINGSEC EDGAR · filed Jul 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 10, 2026 · fetched Nov 12, 2026